IL15 and cancer: However, the splenocytes derived from the mice immunized with the IL-15:IL-15Rα-B16F10-OVA vaccine showed a significantly enhanced OVA-specific cytotoxicity against both B16F10-OVA and E.G7-OVA cancer cells compared with those from the groups infected with control BV or no virus at all the ratios.